ClinicalTrials.gg
Drug

Rosuvastatin clinical trials

Also written Crestor and Crestor 20mg.

studies test it
405
open now
26
in phase 3
106
first study started
1999

How each study uses rosuvastatin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the rosuvastatin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Approvals

The first approval found in each region, with its record

United States
12 Aug 2003 · CRESTOR · NDA 021366 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorisations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Rosuvastatin
272
Rosuvastatin 20mg
17
Rosuvastatin Calcium
9
Rosuvastatin 10mg
7
Rosuvastatin 5mg
6

Brand

Crestor
133
Crestor 20mg
2
Crestor 10mg
1
CRESTOR® 40mg
1

In one entry with another drug

Given together, or one or the other

CKD-828, D097, D337
6
Ezetimibe/Rosuvastatin
4
Rosuvastatin/ezetimibe
2
Rosuvamibe Tab.
2

Studies by the year they started

404 studies that test it; most in 2014 (34)

Studies that test rosuvastatin, by start year
YearStudies
19991
20001
20013
200212
200312
200410
20055
200617
200713
200815
200912
201023
201119
201220
201321
201434
201533
201619
201716
20188
20197
202023
202117
20228
202317
202410
202515
202613

By phase

A phase 1/2 study counts in both.

Early Phase 1
8
Phase 1
104
Phase 2
63
Phase 3
106
Phase 4
114
No phase
28

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 175 · Other 230

AstraZeneca (63) · Chong Kun Dang Pharmaceutical (8) · Boehringer Ingelheim (7) · Yuhan Corporation (7) · Boryung Pharmaceutical Co., Ltd (7) · Organon and Co (6) · Radboud University Medical Center (6) · Government Dental College and Research Institute, Bangalore (6)

Often tested with

Tested in the same studies.

Atorvastatin (48) · Ezetimibe (30) · Metformin (18) · Telmisartan (17) · Digoxin (15) · Simvastatin (14) · Amlodipine (11) · Furosemide (8)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 4 phase 3 studies under way

Rosuvastatin is the comparator. A study of two new drugs counts under both.

Reaching primary completion within a year · 12, 1 in phase 3

Studies that test rosuvastatin, phase 3 first.

Studies

Open first, then newest update. How each study uses rosuvastatin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 405

See all 405 studies that test rosuvastatin →

Given beside what is tested · 135 — rosuvastatin is usual care or a partner of the new treatment

Showing 20 of 135.

As the comparator · 42 — what is tested is compared with rosuvastatin

Showing 20 of 42.

Codes

What other systems call rosuvastatin · ClinicalTrials.gg INT006533

  • MeSH (NLM) D000068718Rosuvastatin CalciumConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 413KH5ZJ73ROSUVASTATINConfirmed FDA, NLM, Wikidata
  • RxNorm 301542Confirmed FDA, Wikidata
  • Wikidata Q415159rosuvastatinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C66523RosuvastatinOne source FDA
  • DrugBank DB01098One source Wikidata

Also registered as rosuvastatin calcium (UNII 83MVU38M7Q · RxNorm 323828).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.